Saxagliptin Hydrochloride eq 2.5mg base tablet |
Company |
Formulation ID |
FDA Description |
Astrazeneca Ab
|
F23993
|
Lactose Monohydrate; Microcrystalline Cellulose; Croscarmellose Sodium; Magnesium Stearate; Polyvinyl Alcohol; Polyethylene Glycol; Titanium Dioxide; Talc; Iron Oxides |
------------------------------------------------------------------------------------ |
|
|
|
Saxagliptin Hydrochloride eq 5mg base tablet |
Company |
Formulation ID |
FDA Description |
Astrazeneca Ab
|
F23994
|
Lactose Monohydrate; Microcrystalline Cellulose; Croscarmellose Sodium; Magnesium Stearate; Polyvinyl Alcohol; Polyethylene Glycol; Titanium Dioxide; Talc; Iron Oxides |
------------------------------------------------------------------------------------ |
|
|
|
Saxagliptin 2.5 mg tablet |
Company |
Formulation ID |
FDA Description |
AstraZeneca; E.R. Squibb & Sons
|
F19734
|
Lactose monohydrate; Magnesium stearate; Croscarmellose sodium; Cellulose, microcrystalline |
------------------------------------------------------------------------------------ |
|
|
|
Saxagliptin 5 mg tablet |
Company |
Formulation ID |
FDA Description |
AstraZeneca; Cardinal Health; E.R. Squibb & Sons; Physicians Total Care
|
F19735
|
Lactose monohydrate; Magnesium stearate; Croscarmellose sodium; Cellulose, microcrystalline |
------------------------------------------------------------------------------------ |
|
|
|